Japanese pharma group takes on new jab that makes immune system attack dangerous protein build-up in brain

Drugmaker follows Eli Lilly in cutting out middlemen and selling directly to patients

Machine intelligence is not yet a substitute for the experimentation that underpins understanding of a disease

Agreement worth up to $1.2bn includes plan for combined flu and Covid shots

AlphaFold 3 aims to reveal biological secrets and boost drug search efforts

Anglo-Swedish drugmaker says availability of newer vaccines hit demand for jab